InvestorsHub Logo

DewDiligence

10/17/14 3:05 PM

#34 RE: DewDiligence #33

SYT's outlook for rest of 2014 (from PR in #msg-107305098):

Mike Mack, Chief Executive Officer, said: “Performance in the second half of the year is primarily driven by Brazil, where the season is just now under way and is still dependent on rainfall. We are seeing strong demand for our newly launched fungicide ELATUS for which we are on track to achieve targeted sales.

For the first nine months of this year profitability has been affected by adverse currency movements [i.e. the strong US dollar] and sales mix. As a result the full year EBITDA margin will be below last year’s level.

In the fourth quarter we expect a higher rate of sales growth and for the full year continue to target integrated sales growth of around 6 percent at constant exchange rates.

DewDiligence

02/04/15 2:31 PM

#40 RE: DewDiligence #33

SYT +3% on 4Q14 results/2015 outlook: #msg-110556971.